Scanner results now published to our DISCORD channel, Join Here: https://discord.gg/fTah76E3SE

Click Here For More Details
Member Login
0
0
Subtotal: $0.00
No products in the cart.

« All Events

  • This event has passed.

AMAM – Data Update and Virtual Presentation on ARX788

February 24, 2023 @ 8:00 am - 5:00 pm

From the event writeup linked below:

  • Virtual presentation to take place on February 24, 2023 at 12:00pm ET
  • Event will feature discussions regarding ARX788, Ambrx’s proprietary anti-HER2 targeting ADC, from key opinion leaders in breast cancer, Hope S. Rugo, M.D., FASCO, and Paula R. Pohlmann, M.D., M.S., Ph.D.
  • Data update for APEX-01, a first-in-human study evaluating the safety and anti-tumor activity of ARX517, Ambrx’s proprietary anti-PSMA ADC, in prostate cancer patients will also be provided

Link to Event PR: https://ir.ambrx.com/news/news-details/2023/Ambrx-Biopharma-to-Host-Analyst-and-Investor-Day-to-Discuss-ARX788-in-Breast-Cancer-and-ARX517-in-Prostate-Cancer/default.aspx

Details

Date:
February 24, 2023
Time:
8:00 am - 5:00 pm
Facebook-f Twitter

No information expressed or distributed by Black Ink Economics constitutes investment, trading, or financial advice. Black Ink Economics mission is to educate people on how to trade and to further their clients knowledge as to the workings of the financial markets and technical indicators. Any information presented or distributed by Black Ink Economics is for education and entertainment purposes only.

© Copyright 2024 — Black Ink Economics, Ltd. Legal